Suuqa suuqa, is-weydaarsiga bangiga maanta
Waraaqda saamiyada ee 71229 shirkadood waqtiga dhabta ah.
Suuqa suuqa, is-weydaarsiga bangiga maanta

Qodobbada saamiyada

Qoraalka dulsaarka ee internetka

Taariikhda saamiyadu soo xigtay

Suuq geynta suuqa

Dakhliga saamiyada leh

Ka faa'iideyso saamiyada shirkadda

Warbixinno maaliyadeed

Saamiyada saamiga shirkadaha. Xaggee lacag lagu maalgeliyaa?

Dakhliga Innate Pharma S.A.

Ka warbixi natiijooyinka dhaqaale ee shirkadda Innate Pharma S.A., dakhliga sanadlaha ee Innate Pharma S.A. ee 2024. Goorma ayuu Innate Pharma S.A. ku soo daabacay warbixinnada maaliyadeed?
Ku dar widgets
Waxaa lagu daraa widgets

Innate Pharma S.A. wadarta dakhliga, dakhliga saafiga ah iyo dhaqdhaqaaqa isbeddelada ee Euro maanta

Dhaqdhaqaaqa dakhliga saafiga ah ee Innate Pharma S.A. ayaa kacay. Isbedelka ayaa loo dhigay 0 €. Dhaqdhaqaaqa dakhliga saafiga ayaa la muujiyay marka la barbar dhigo warbixintii hore. Innate Pharma S.A. Dakhliga saafiga ah hadda waa -26 825 000 €. Waa kuwan tilmaamayaasha dhaqaale ee ugu weyn Innate Pharma S.A.. Warbixinta maaliyadeed ee ku taal shaxda Innate Pharma S.A. waxay kuu oggolaaneysaa inaad si cad u aragto dhaqdhaqaaqa hantida go'an. Innate Pharma S.A. Dakhliga guud ee garaafka waxaa lagu muujiyey huruud. Qiimaha dhammaan Innate Pharma S.A. hantida ku taal garaafka waxaa lagu muujiyey cagaar.

Taariikhda Warbixinta Wadarta dakhliga
Dakhliga guud waxaa lagu xisaabiyaa iyadoo lagu dhufanayo tirada alaabta la iibiyay qiimaha alaabta.
iyo Isbeddel (%)
Isbarbardhiga warbixinta saddex-biloodlaha ah ee sannadkan iyadoo warbixinta saddex-biloodlaha ah ee sannadkii hore.
Dakhliga saafiga ah
Dakhliga saafiga ah waa dakhliga shirkadda laga jaray qiimaha alaabta iibinta, kharashyada iyo canshuurta muddada warbixinta.
iyo Isbeddel (%)
Isbarbardhiga warbixinta saddex-biloodlaha ah ee sannadkan iyadoo warbixinta saddex-biloodlaha ah ee sannadkii hore.
31/12/2020 16 853 000 € +26.43 % ↑ -26 825 000 € -
30/09/2020 16 853 000 € +26.43 % ↑ -26 825 000 € -
30/06/2020 18 372 500 € -37.884 % ↓ -5 167 000 € -178.051 % ↓
31/03/2020 18 372 500 € -37.884 % ↓ -5 167 000 € -178.051 % ↓
31/12/2019 13 329 500 € - -16 999 500 € -
30/09/2019 13 329 500 € - -16 999 500 € -
30/06/2019 29 577 500 € - 6 620 000 € -
31/03/2019 29 577 500 € - 6 620 000 € -
Muuji:
In

Warbixinta dhaqaalaha Innate Pharma S.A., jadwalka

Taariikhihii ugu dambeeyay ee Innate Pharma S.A. Bayaanka maaliyadeed waxaa laga heli karaa khadka tooska ah: 31/03/2019, 30/09/2020, 31/12/2020. Taariikhaha caddaymaha maaliyadeed waxaa si adag u nidaamiya sharciga iyo bayaanada maaliyadeed. Warbixinta ugu dambeysa ee dhaqaalaha ee Innate Pharma S.A. ayaa laga heli karaa khadka tooska ah taariikhdaas oo kale - 31/12/2020. Dakhliga saafiga ah Innate Pharma S.A. waa dakhliga shirkadda laga jaray qiimaha alaabta iibinta, kharashyada iyo canshuurta muddada warbixinta. Dakhliga saafiga ah Innate Pharma S.A. waa -26 825 000 €

Taariikhda warbixinta maaliyadeed Innate Pharma S.A.

Hantida hadda jirta Innate Pharma S.A. waa shay xisaabeed oo ka dhigan qiimaha hantida oo dhan oo lagu beddeli karo lacag hal sano ah. Hantida hadda jirta Innate Pharma S.A. waa 173 451 000 € Sinnaanta Innate Pharma S.A. waa wadarta dhammaan hantida mulkiilaha ka dib marka laga gooyo wadarta guud ee hantida. Sinnaanta Innate Pharma S.A. waa 155 976 000 €

31/12/2020 30/09/2020 30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Dakhli guud
Dakhliga Guud waa faa'idada ay shirkaddu hesho ka dib marka laga jaro qiimaha wax soo saarka iyo iibinta alaabada iyo / ama kharashka bixinta adeegyadeeda.
3 296 000 € 3 296 000 € 2 623 000 € 2 623 000 € -7 800 500 € -7 800 500 € 11 285 500 € 11 285 500 €
Sicirka qiimaha
Kharashku waa qiimaha guud ee wax soo saarka iyo qaybinta alaabooyinka iyo adeegyada shirkadda.
13 557 000 € 13 557 000 € 15 749 500 € 15 749 500 € 21 130 000 € 21 130 000 € 18 292 000 € 18 292 000 €
Wadarta dakhliga
Dakhliga guud waxaa lagu xisaabiyaa iyadoo lagu dhufanayo tirada alaabta la iibiyay qiimaha alaabta.
16 853 000 € 16 853 000 € 18 372 500 € 18 372 500 € 13 329 500 € 13 329 500 € 29 577 500 € 29 577 500 €
Dakhliga hawlgalka
Dakhliga hawlgalku waa dakhliga ka soo jeeda ganacsiga asaasiga ah ee shirkadda Tusaale ahaan, dukaanno wuxuu soo saaraa dakhliga iibinta alaabta, dhakhtarku wuxuu ka helaa dakhliga ka yimid adeegyada caafimaad ee isagu / iyadu bixiso.
- - - - 13 329 500 € 13 329 500 € 29 577 500 € 29 577 500 €
Dakhliga shaqada
Dakhliga hawlgalku waa qadar xisaabeed oo cabbiraya caddadka faa'iidada laga helo hawlaha ganacsiga, ka dib marka laga jaro kharashyada hawlgalka, sida mushaharka, qiimo-dhaca iyo kharashka alaabta la iibiyay.
-5 099 500 € -5 099 500 € -4 174 000 € -4 174 000 € -18 254 000 € -18 254 000 € 4 728 000 € 4 728 000 €
Dakhliga saafiga ah
Dakhliga saafiga ah waa dakhliga shirkadda laga jaray qiimaha alaabta iibinta, kharashyada iyo canshuurta muddada warbixinta.
-26 825 000 € -26 825 000 € -5 167 000 € -5 167 000 € -16 999 500 € -16 999 500 € 6 620 000 € 6 620 000 €
Kharashka R & D
Kharashka cilmi baarista iyo horumarinta - kharashka cilmi baarista si loo hagaajiyo alaabooyinka iyo nidaamyada hadda jira ama lagu horumariyo alaabo iyo habab cusub.
- - - - - - - -
Kharashka hawlgalka
Kharashka hawlgalku waa kharashyada ganacsigu ka yimaaddo natiijada hawlgalka ganacsiga caadiga ah.
21 952 500 € 21 952 500 € 22 546 500 € 22 546 500 € 31 583 500 € 31 583 500 € 24 849 500 € 24 849 500 €
Hantida hadda jirta
Hantida hadda jirta waa shay xisaabeed oo ka dhigan qiimaha hantida oo dhan oo lagu beddeli karo lacag hal sano ah.
173 451 000 € 173 451 000 € 163 689 000 € 163 689 000 € 237 605 000 € 237 605 000 € 216 678 000 € 216 678 000 €
Wadarta hantida
Tirada guud ee hantida waa lacagta caddaanka ah ee kaashka ah ee kaashka ah ee ururka, xusuusta deynta, iyo hantida la taaban karo.
307 423 000 € 307 423 000 € 333 066 000 € 333 066 000 € 401 361 000 € 401 361 000 € 352 555 000 € 352 555 000 €
Lacag caddaan ah
Lacagta hadda jirta waa wadarta dhammaan lacagta caddaanka ah ee ay shirkadu ku leedahay taariikhda warbixinta.
136 792 000 € 136 792 000 € 131 542 000 € 131 542 000 € 202 887 000 € 202 887 000 € 149 376 000 € 149 376 000 €
Deynta joogtada ah
Deynta hadda waa qayb ka mid ah deynta la bixin karo sanadka dhexdiisa (12 bilood) waxaana lagu tilmaamaa inay tahay masuuliyad hadda jirta iyo qayb ka mid ah raasumaalka shaqada ee netka.
- - - - 121 822 000 € 121 822 000 € 94 549 000 € 94 549 000 €
Wadarta lacagta
Lacagta wadarta guud ee lacagta caddaanka ah waa caddadka dhammaan lacagaha ay shirkadu ku leedahay xisaabteeda, oo ay ku jiraan lacag yar iyo lacago lagu hayo bangiga.
- - - - - - - -
Deynta guud
Deynta guud waa isku darka labadaba muddada gaaban iyo muddada dheer. Deymaha muddada gaaban waa kuwa ah in la bixiyo sannad gudaheed. Deynta muddada dheer waxaa badanaa ku jira dhammaan waajibaadyada ay tahay in dib loogu celiyo hal sano ka dib.
- - - - 183 945 000 € 183 945 000 € 171 289 000 € 171 289 000 €
Saameynta deynta
Deynta guud ee hantida guud waa saamiga dhaqaale ee muujinaya boqolleyda hantida shirkaddu u taagan tahay deynta.
- - - - 45.83 % 45.83 % 48.59 % 48.59 %
Sinnaanta
Sinnaanta waa wadarta dhammaan hantida mulkiilaha ka dib marka laga gooyo wadarta guud ee hantida.
155 976 000 € 155 976 000 € 207 764 000 € 207 764 000 € 217 416 000 € 217 416 000 € 181 266 000 € 181 266 000 €
Socodka lacagta
Socodka lacagta caddaanka ah waa caddadka saafiga ah ee lacag caddaan ah iyo lacago isu dhigma oo ku wareegaya urur.
- - - - -12 355 500 € -12 355 500 € 29 817 500 € 29 817 500 €

Warbixinta maaliyadeed ee ugu dambeysay ee dakhliga Innate Pharma S.A. wuxuu ahaa 31/12/2020. Sida laga soo xigtay warbixintii ugu dambeysay ee ku saabsan natiijooyinka dhaqaale ee shirkadda Innate Pharma S.A., dakhliga guud ee Innate Pharma S.A. wuxuu ahaa 16 853 000 Euro waxaana loo beddelay +26.43% marka loo eego sannadkii hore. Dakhliga saafiga ah ee Innate Pharma S.A. ee rubucii ugu dambeeyay wuxuu ahaa -26 825 000 €, dakhliga saafiga ah wuxuu badalay -178.051% marka la barbardhigo sannadkii la soo dhaafay.

Kharashka saamiyada Innate Pharma S.A.

Maaliyadda Innate Pharma S.A.